Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Study
Latest Information Update: 04 Nov 2021
Price :
$35 *
At a glance
- Drugs Sodium nitrite (Primary)
- Indications COVID 2019 infections; Lung injury; Respiratory insufficiency
- Focus Therapeutic Use
- Sponsors Hope Pharmaceuticals
- 11 Sep 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 22 Jul 2020 Status changed from not yet recruiting to recruiting.
- 03 Jul 2020 Planned initiation date changed from 1 Jun 2020 to 9 Jul 2020.